Kristie Rosa

Articles

Epoetin Alfa Biosimilar Launched at Significant Discount in US

November 21, 2018

Epoetin alfa-epbx (Retacrit), the biosimilar to epoetin alfa (Procrit/Epogen), has been launched in the United States at a significant discount. The shipment of the biosimilar to wholesalers throughout the United States began on Nov. 12, 2018.